ArticleInternational journal of molecular sciences2025

Monitoring of (Leukemia-Specific) Immune Cells in Stages, Treatment Groups and in the Course of Disease and Therapy Contributes to Qualify Antileukemic Potential and Survival in Patients with AML.

Julian Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.